Qingdao Vland Biotech Inc. (603739.SS) SHH

12.91

-0.24(-1.83%)

Updated at June 02 03:00PM

Currency In CNY

Valuation

Market Cap3.53B
Enterprise Value3.93B
P/E Ratio41.83
PEG Ratio2.01
Price/Sales Ratio2.33
Price/Book Ratio1.82
Enterprise/Revenue2.67
Enterprise/EBITDA16.21

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.09

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue1.37B
Revenue/Share5.54
Gross Profit611.97M
EBITDA258.27M
Net Income69.81M
Diluted EPS0.28

Balance Sheet

Total Cash497.38M
Total Cash/Share1.97
Total Debt700.36M
Total Debt/Equity0.39
Current Ratio1.19
Book Value Per Share7.61

Price History

52-Week Change-6.58
52-Week High18.41
52-Week Low12.61
Moving Average 50 Days14.59
Moving Average 200 Days14.83

Statistics

Average Volume5.39M
Shares Outstanding253.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.77
Payout Ratio0.49
Last Split Factor7:5
Last Split DateMay 25, 2021